Company Financials

Arcutis Biotherapeutics, Inc. Financials

United States dollar

business Arcutis Biotherapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: ARQT

Market Capitalization $3.55 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -25.00
Forward PE 64.53
Price to Sales TTM $11.19
Price to Book MRQ $22.10
Enterprise to Revenue 10.95
Enterprise to EBITDA -104.85

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -13.94%
Operating Margin 8.59%
Return on Assets TTM -5.91%
Return on Equity TTM -28.17%

Income Statement

Revenue TTM $317,928,992
Revenue per Share TTM $2.52
Quarterly Revenue Growth 121.70%
Gross Profit TTM $286,016,992
EBITDA $-33,189,000
Net Income to Common TTM $-44,324,000
Diluted EPS TTM $-0.34
Quarterly Earnings Growth YoY 121.69%

Balance Sheet

Total Cash MRQ $191,068,000
Total Cash per Share MRQ $1.56
Total Debt MRQ $
Total Debt to Equity MRQ 71.98
Current Ratio MRQ 3.50
Book Value per Share MRQ $1.31

Cash Flow

Operating Cash Flow TTM $-32,558,000
Levered Free Cash Flow TTM $-42,323,376

ARQT Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 120,288,146
Float Shares 89,408,276
Avg 10 Volume 1,787,880
Avg 30 Volume None
Shares Short 13,235,954
Short Ratio 5.63
Short % of Shares 13.28%
% Held by Insiders 1.68%
% Held by Institutions 108.16%

Stock Price Summary

Beta 1.70
Fifty Two Week Low $11.13
Fifty Two Week High $31.77
Fifty Two Week Change 49.28%
Day 50 MA $26.99
Day 200 MA $18.41

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date